Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 26, 2022; 10(33): 12089-12103
Published online Nov 26, 2022. doi: 10.12998/wjcc.v10.i33.12089
Figure 2
Figure 2 The Kaplan-Meier survival of patients with esophageal cancer who were classified according to pyruvate dehydrogenase A1 expression. A and B: In esophageal cancer, patients with low pyruvate dehydrogenase A1 (PDHA1) expression levels had better overall survival (A) and progression-free survival (B) than patients with high PDHA1 expression levels. The significance of the difference between high and low expression was calculated using the log-rank test.